TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

JPMORGAN CHASE & CO's Holding History (CIK: 0000019617)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 595,000 Value ($000) $843 Avg Close — Range —
Q3 2025
Shares 556,000 Value ($000) $634 Avg Close — Range —
Q2 2025
Shares 596,000 Value ($000) $569 Avg Close — Range —
Q1 2025
Shares 871,000 Value ($000) $903 Avg Close — Range —
Q4 2024
Shares 900,000 Value ($000) $860 Avg Close — Range —
Q3 2024
Shares 900,000 Value ($000) $777 Avg Close — Range —
Q4 2023
Shares 125,000 Value ($000) $81 Avg Close — Range —
Q3 2023
Shares 125,000 Value ($000) $81 Avg Close — Range —
Q2 2023
Shares 125,000 Value ($000) $102 Avg Close — Range —
Q1 2023
Shares 125,000 Value ($000) $123 Avg Close — Range —